While the outgrowth of SUDHL-4 was not affected by the dose of CB CD19-CAR T cells, the low amount (E: T of 1:1) of CB CD19-CAR T cells still led to anti-tumor activity against CB CD19-CAR T cells. The gene discussed is CD19; the disease is neoplasm.